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Abstract A growing patient demand for a youthful skin
appearance with a favorable body shape has led to the recent
development of new noninvasive body contouring techniques.
We have previously demonstrated that the combination of
bipolar radiofrequency (RF) and optical energies with tissue
manipulation is an efficient reshaping modality. Here, we
investigated the efficacy and safety of a new high-power
version of this combined technology, in terms of adipose
tissue reduction and skin tightening. Thirty-five patients re-
ceived one treatment per week over 6 weeks to their abdomen/
flank, buttock, or thigh areas andwere followedup to 3months
post completion of the treatment protocol. This new device
has an increased power in the bipolar RF, as this parameter
appears to be the most important energy modality for volume
reduction. Patient circumferences were measured and compar-
isons of baseline and post treatment outcomes were made.
Diagnostic ultrasound (US) measurements were performed in
12 patients to evaluate the reduction in adipose tissue volume,
and a cutometer device was used to assess improvements in
skin tightening. We observed a gradual decline in patient
circumferences from baseline to post six treatments. The
overall body shaping effect was accompanied with improve-
ment in skin tightening and was clearly noticeable in the
comparison of the before and after treatment clinical photo-
graphs. These findings correlated with measurements of adi-
pose tissue volume and skin firmness/elasticity using diagnos-
tic US and cutometer, respectively. The thickness of the fat
layer showed on average a 29 % reduction between baseline
and the 1-month follow up. The average reduction in the
circumference of the abdomen/flanks, buttocks, and thighs
from baseline to the 3-month follow-up was 1.4, 0.5, and
1.2 cm, respectively, and 93 % of study participants demon-
strated a 1–60 % change in fat layer thickness. Patients sub-
jectively described comfort and satisfaction from treatment,
and 97 % of them were satisfied with the results at the follow-
up visit. The application of high-power RF energy combined
with infrared (IR), mechanical massage, and vacuum appears
to be an effective modality for the reduction in circumferences
of the abdomen/flank, buttock and thigh regions, and the
improvement of skin appearance. The present study per-
formed with a new device suggests that the underlying mech-
anism of action is reduction in the subcutaneous adipose tissue
volume and intensification of dermal matrix density.
Keywords VelaShape II . Circumferential reduction . Body
contouring . Skin tightening
Introduction
Localized subcutaneous fat deposits and tissue laxity are of
growing concern among cosmetic patients, the contributing
factors of which include chronological aging, photoaging, as
well as changes in body dimensions due to pregnancy and
significant weight loss. The most popular body contouring
approaches used to improve the cosmesis of subcutaneous fat
deposits and skin laxity are surgical and include liposuction,
abdominoplasty, and thigh lifts, among other procedures.
However, in tandem with cosmetic patients’ desire for a
favorable body shape is their increasing demand for noninva-
sive treatment approaches that are painless, safe, and require
little to no downtime. This increasing demand has led to the
rapid growth and development of noninvasive, nonsurgical
treatment techniques. Although surgical techniques can result
in the most pronounced outcomes in respect to improved body
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contouring results, they are also associated with inherent risks
as well as prolonged recovery times. These factors, in combi-
nation with today’s cosmetic patients’ active lifestyles and
coupled with their desire for noninvasive treatment options
have further popularized noninvasive, nonsurgical treatment
approaches.
The first most common and available noninvasive treat-
ments for body contouring were based on nonthermal me-
chanical rollers and suction systems that were thought to cause
vasodilatory effects, which enhance lymphatic drainage in fat
deposits and improve microcirculation. Over the past couple
of years, however, the technology has moved towards the use
of thermal-based suction devices which combine radiofre-
quency (RF) with or without infrared energies and mechanical
massage. The application of energy to the skin’s surface
produces heat in the dermis and subcutaneous tissues with
subsequent induction of collagen denaturation and
neocollagenesis, resulting in tissue tightening [1–4]. The RF
technology delivers a thermal stimulus to the skin and super-
ficial adipose tissue causing a thickening of the dermis and
enhancement of fat cell metabolism, resulting in a reduction in
skin laxity and adipocyte volume [1–5].
The VelaShape device (Syneron Medical Ltd. Yokneam,
Israel) incorporates four treatment modalities including pulsed
vacuum and mechanical massage, bipolar RF energy, and IR
light, the latter of which preheats the targeted tissue, mitigat-
ing impedance, and thereby allowing greater attraction of the
RF current and deeper penetration of RF energy into the
targeted tissues [1–6]. This study evaluated the efficacy and
safety of the VelaShape II device (Syneron Medical Ltd.,
Yokneam, Israel), a new high-power version of its predecessor
the VelaShape, in terms of adipose tissue reduction and skin
tightening.
Materials and methods
In this prospective, two-center clinical trial conducted at
Skinpulse Dermatology and Laser Centre, Geneva, Switzer-
land, and Dr. Morren’s private practice, Leuven, Belgium,
treatment was performed using the VelaShape II system, a
device that combines four different technologies including
broadband IR (infrared), bipolar RF-pulsed vacuum and mas-
sage rollers. The broadband IR light spectrum is 700–
2,000 nm with a high pass filter, at up to 35 W. The RF
frequency is 1 MHz and up to 60 W. Pulsed vacuum was set
up at 200 mbar of negative pressure.
The combination of the IR and pulsed vacuum coupled RF
technologies causes a deep heating of the connective tissue
including the fibrous septae. This in turn promotes an increase
in collagen deposition and cellular metabolism resulting in a
localized reduction in skin laxity and volume [1–4]. The
additional mechanical tissue manipulation by the vacuum
and massage rollers, causes an immediate increase in the local
circulation and enhances lymphatic drainage, both effects of
which are considered to be essential components for healthy
skin structure. The VelaShape II system has two applicators,
namely the Vsmooth with a 40 mm×40 mm spot size and the
Vcontour with a 30 mm×30mm spot size. The applicators are
fitted with a replaceable cap that has a treatment chamber, into
which the targeted skin is repeatedly drawn during treatment
via mechanical manipulation and is exposed to IR and RF
energies. The user can individualize treatment by adjusting the
energies and vacuum levels according to the patient and
anatomical site treated.
The study included 35 healthy adult female patients who
were between 21 and 58 years of age (mean age 43) with
clinically appreciable skin laxity and localized subcutaneous
fat deposits on the abdomen/flanks, buttocks or thigh regions,
and Fitzpatrick skin types I to III. Patient inclusion criteria
were the presence of at least 20 mm of subcutaneous fat
(assessed by ultrasound) and the presence of lax skin and
cellulite. Study exclusion criteria were mainly pregnancy,
lactation, and any kind of previous cosmetic treatment in these
areas for the last 12months. Every patient signed the informed
consent prior to the study. Study participants were treated for
circumferential reduction on the abdomen/flanks (n=32), but-
tocks (n=14), and thighs (n=16) and received a total of six
treatments performed once or twice a week. All of the treat-
ments in this study were performed with the Vsmooth large
spot applicator using RF energy of 60 W and IR energy of up
to 35W. Each procedure was performed using the established
and standardized treatment protocol of the VelaShape II sys-
tem, which at the time of this study was a new device with
increased power. The pulsed vacuum was typically set at level
2 (200 mbar of negative pressure). Treatment sessions typi-
cally lasted from 35 to 45 min, in which the goal was to treat
the area until the target tissue temperature of between 39–
41 °C has been reached and maintain it for at least 5 min per
10×10 cm2 zone (per the VelaShape II user manual). The
temperature maintained was measured at skin level using an
external thermometer. It has been shown that in the tempera-
ture range 37–44 C, skin blood perfusion increases 10 times,
muscle about nine times, and fat only two times [13]. The skin
cools much faster than the fat because of the increased blood
flow, thus the temperature is maintainedmuch longer in the fat
layer than what we measure on the skin.
Patients did not gain or lose weight significantly during the
course of the study, as theywere weighed at each visit. Various
clinical evaluations were performed by an independent ob-
server at baseline, after the fourth treatment, immediately after
the last treatment, and 1 and 3 months after the last treatment.
Objective clinical assessments included changes in the fat
layer thickness and skin firmness/elasticity, which were per-
formed using an external ultrasound probe (Echoblaster 128,
Telemed Ltd., Vilnius, Lithuania) and a cutometer,
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respectively. Both the ultrasound and cutometer technologies
used to ascertain the objective clinical changes achieved in
this study are FDA-approved modalities. Measurements were
taken in three consecutive repetitions, and the average score
(in mm) was recorded. Improvement evaluation was per-
formed by the physician using the following percentile cate-
gories: 0, 1–24, 25–49, 50–74, and 75–100 %. All clinical
photographs were taken with a medical standardized system
(Profect Full Body System, Profect Medical Technologies
LLC, Pound Ridge, NY, USA). Patients evaluated treatment
outcome satisfaction based on the following satisfaction scale:
not satisfied, slightly satisfied, satisfied, very satisfied, and
extremely satisfied. Safety and patients’ report of treatment-
associated sensation was monitored throughout the study.
Results
All of the patients met the inclusion/exclusion criteria of the
study and signed an informed consent for US and cutometer
measurements prior to its initiation. Results showed that all of
the 35 healthy adult women (aged 21 to 58 years, mean
43 years) completed the clinical trial. The Fitzpatrick skin
type allocation was 9 % type I, 85 % type II, and 6 % type
III. The 35 patients included in the study received VelaShape
II treatment to one or more anatomical sites including the
abdomen/flanks (n=32), buttocks (n=14), and thighs (n=
16). The average reduction in the circumference of the
abdomen/flanks, buttocks, and thighs from baseline to the 3-
month follow-up was 1.4, 0.5, and 1.2 cm, respectively, while
the SD was 2, 0.7, and 3.3 cm, respectively. P value
(Wilcoxon signed rank test for single group median) was
0.0004, 0.0446, and 0.1503, respectively (Table 1).
The thickness of the fat layer as per the comparative ultra-
sound measurements taken showed on average a 29 % reduc-
tion between baseline and the 1-month follow-up, and 93% of
study participants demonstrated a 1–60 % change in fat layer
thickness (Fig. 3).
The physician’s evaluation measurements revealed that
almost all patients had some level of overall improvement in
adipose tissue reduction and skin tightening in the treated
areas, with 60 % of patients showing a 1–24 % improvement,
27 % showing a 25–49 % improvement, and 5 % showing a
50–74 % improvement, while only 8 % of patients showed no
improvement in the treated anatomical sites (Fig. 1). At the
final follow-up visit, 97 % of patients expressed an overall
satisfaction with the treatment outcomes, including 3 % being
extremely satisfied, 32 % very satisfied, 52 % satisfied, and
10% slightly satisfied. The overwhelmingmajority of patients
tolerated the treatments well, with 69 % of patients subjec-
tively rating the treatment as very comfortable, 21 % comfort-
able, 6 % somewhat comfortable, and 3 % somewhat uncom-
fortable, while only 3 % perceived the treatment as very
uncomfortable. Side effects of treatment included transient
erythema and edema in all patients and two patients with
bruising at the treated site. Adverse events included a burn
to the abdomen in one patient, which could be treated with
remedial therapy.
Discussion
This study supports the safety and efficacy of the VelaShape II
system for the improvement in circumferential reduction and
skin laxity in the abdomen/flanks, buttocks, and thigh regions
(Fig. 2). The safety and efficacy of an older version of the







Mean 1.209375 1.428125 0.475468
S.E.M. 0.8339692 0.362374 0.195029
SD 3.3358766 2.049899 0.729733
Variance 11.128073 4.202087 0.532511
Coef. var. 2.7583476 1.435378 1.534768
Minimum −1.5 −3.5 −0.5
Maximum 13 6 2
Sum 19.35 45.7 6.656557
N 16 32 14
P value (Wilcoxon signed rank test
for single group median)
0.1504513 0.000365 0.044603
P value (Kruskal-Wallis test) 0.1267881158
Fig. 1 Fat thickness change at FU visit Fig. 2 Overall satisfaction—FU
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device (VelaSmooth, Syneron Medical Ltd., Yokneam, Israel)
has already been demonstrated in previous clinical trials in
terms of circumference reduction and cellulite improvement,
mainly in thighs and buttocks [6–11]. The VelaShape (imme-
diate predecessor to the VelaShape II) was the first device to
achieve an FDA indication for circumferential reduction in
2007, following clinical trials performed on thighs [1, 6,
9–14].
The clinical effect seen with VelaShape treatment is
thought to occur as follows: the pulsed vacuum combined
with the action of massage rollers causes a vasodilation as
well as an increased local circulation and lymphatic drainage
in the treated area. The subsequent increase in available oxy-
gen can facilitate an increase in the localized fat metabolism.
In addition, the heat generated from the application of IR and
RF energies theoretically increases the available oxygen, fur-
ther enhancing fat metabolism and causes the adipocytes to
shrink as they break down the fat. The mechanical massage
also enhances the flow of these breakdown products to the
lymphatic system and stretches the fibrous septae. The colla-
gen fibers in the dermis and fibrous septae shrink, resulting in
smaller fat chambers and skin tightening. The heat energy also
causes collagen shrinkage and stimulates the fibroblasts to
produce new collagen fibers. Taken together, these combined
actions result in circumferential reduction and improvements
in skin laxity and the appearance of cellulite (Fig. 3).
Among other changes, one of the pivotal upgrades made to
the VelaShape II device from its immediate predecessor is an
increase in power in the bipolar RF energy by 20 % to 60 W.
The increased power in the bipolar RF energy appears to be
the most important energy modality that can impact and
enhance volume reduction. The 40 mm×40 mm Vsmooth
large spot applicator used in this study can emit RF energy
of 60Wand IR of up to 35W. The simultaneous application of
IR and RF heat energies is combined with mechanical tissue
manipulation achieved with massage rollers and pulsed, the
latter of which allows for a higher penetration depth for higher
peak heating of the subcutaneous tissue.
The peak temperature reached in the tissues and the time
over which that temperature is maintained are two important
factors that impact tissue tightening. Achieving and maintain-
ing a peak temperature over a period of time result in a
progressive skin tightening and subsequent measureable re-
ductions in circumference [15]. It is widely known that clin-
ical results are dependent on the maintenance of targeted
tissue temperature over 40 °C [2, 14]. Therefore, one of the
goals during treatment with the device in this study was to
reach and maintain a target tissue temperature between 40–
41 °C for at least 5 min per 10×10 cm2 zone. Data has shown
that at 10- and 15-mm tissue depths, the temperature elevates
after VelaShape treatment and is maintained over 40 °C, long
after completion of treatment enabling an enhanced thermal
effect for a more effective clinical outcome [14]. It is thought
that the synergy of the combined technologies of IR and RF
energies (heating the tissue up to 3 and 15 mm, respectively),
as well as vacuum and massage rollers can result in improved
results that may last longer compared to previous versions of
the device. The 20 % higher bipolar RF energy of the
VelaShape II device up to 60 W enables a deeper and more
intense heating of the dermis and subcutaneous tissues,
allowing for clinicians to reach the target temperature quicker,
resulting in a reduction of treatment times, particularly when
compared to earlier versions of the device.
Limitations of this study include a relatively small patient
cohort as well as the lack of extended follow-up evaluations
and untreated control subjects. In addition, each abdomen
measurement could ideally be taken at the same point in the
respiratory cycle in order to better address measurement bias.
Moreover, the timing of measurements in respect to the pa-
tients’ menses (i.e., bloating) could potentially alter circum-
ference measurements. One can also assume that large meals
or volumes of fluid taken directly prior to circumference
measurement can affect the measurement result [16]. Future
clinical trials that can address these points could be part of the
focus of future clinical trials, which may further support the
clinical outcomes achieved here.
Conclusion
In conclusion, the combination of bipolar RF, IR light, and
mechanical tissue manipulation with pulsed vacuum and mas-
sage rollers appears to be a safe and effective therapeutic
modality for the reduction of adipose tissue volume and skin
Fig. 3 Four treatment results, reduction of fat thickness is visible and stable at 1 and 3 months FU
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tightening. It is suggested that the 20 % higher bipolar
RF energy available in the VelaShape II device may
also result in a more intense heating of the targeted
tissues, resulting in both faster treatment times as well
as improved clinical outcomes.
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